Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Portal Vein Tumour Thrombosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01952353
What this trial is testing

Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion

Who this might be right for
Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Sun Yat-sen University 330
Large-scale testing (Phase 3)UnknownNCT04319484
What this trial is testing

Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusLiver Transplantation
RenJi Hospital 108
Not applicableStudy completedNCT04618367
What this trial is testing

HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

Who this might be right for
Carcinoma, HepatocellularLiver NeoplasmsSintilimab+1 more
Sun Yat-sen University 30
Post-approval studies (Phase 4)Study completedNCT03007212
What this trial is testing

Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein Thrombosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Ain Shams University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06664996
What this trial is testing

Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 33
Testing effectiveness (Phase 2)Ended earlyNCT05137899
What this trial is testing

Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumour Thrombosis
Ontario Clinical Oncology Group (OCOG) 1
Not applicableStudy completedNCT05535998
What this trial is testing

TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone for Hepatocellular Carcinoma With PVTT

Who this might be right for
Hepatocellular Carcinoma
Yunfei Yuan 743
Not applicableStudy completedNCT06005883
What this trial is testing

Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring

Who this might be right for
Hepatocellular CarcinomaPortal Vein ThrombosisPrognosis
Keimyung University Dongsan Medical Center 332
Large-scale testing (Phase 3)Not Yet RecruitingNCT06089382
What this trial is testing

Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection

Who this might be right for
Hepatocellular Carcinoma
Tongji Hospital 104
Testing effectiveness (Phase 2)Looking for participantsNCT06823375
What this trial is testing

SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis

Who this might be right for
HCC
Chinese University of Hong Kong 40
Not applicableUnknownNCT05491889
What this trial is testing

Outcome of Hepatocellular Carcinoma Patients With Portal Vein Thrombosis After Trans-Arterial Chemo Embolization

Who this might be right for
Hepatocellular Carcinoma
Assiut University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07483359
What this trial is testing

Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma (HCC)Portal Vein Tumor Thrombus
First Hospital of China Medical University 38
Not applicableStudy completedNCT06881433
What this trial is testing

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 1,649
Not applicableStudy completedNCT07252570
What this trial is testing

Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes

Who this might be right for
Biliary Tract NeoplasmsPancreatic NeoplasmPortal Hypertension+1 more
Centre Hospitalier Universitaire de Nice 63
Not applicableLooking for participantsNCT06622031
What this trial is testing

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusSystemic Therapy
Sun Yat-sen University 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06632522
What this trial is testing

Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .

Who this might be right for
Liver Cancer
Beijing Tsinghua Chang Gung Hospital 46
Large-scale testing (Phase 3)Study completedNCT02774187
What this trial is testing

Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 247
Testing effectiveness (Phase 2)UnknownNCT06210334
What this trial is testing

HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)

Who this might be right for
Hepatocellular Carcinoma With PVTT
Li Xiao Wei 54
Large-scale testing (Phase 3)WithdrawnNCT00238160
What this trial is testing

Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer

Who this might be right for
Localized Resectable Adult Primary Liver CancerStage III Childhood Liver Cancer
Kyoto University
Testing effectiveness (Phase 2)Study completedNCT03009461
What this trial is testing

Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis

Who this might be right for
HepatoCellular CarcinomaPortal Vein Thrombosis
Peking University 64
Next Page